NetworkNewsBreaks – Pressure BioSciences Inc. (P
Post# of 1354
(Total Views: 114)
Posted On: 02/26/2018 4:59:31 PM
NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters Agreement to Create Unique Analytical System Using Patented Pressure Cycling Technology
Pressure BioSciences (OTCQB: PBIO) recently entered a global co-marketing and distribution agreement with ISS, Inc. to create an advanced high pressure optical spectroscopy system utilizing PBIO’s patented pressure cycling technology (“PCT”). An article further discussing the agreement reads: “A leading developer and provider of innovative high pressure-based solutions to the global life sciences industry, Pressure BioSciences, Inc. (OTCQB: PBIO) has entered a two-year agreement with ISS, Inc., a prominent designer and manufacturer of advanced scientific instruments with more than 30 years of experience in the field. Under the agreement, the two companies will join their marketing and distribution efforts worldwide, as well as their own technologies to create an advanced high pressure optical spectroscopy system that’s expected to generate significant data that could be critical to the discovery and development of new biopharmaceutical diagnostics and drugs, according to a Pressure BioSciences press release issued on February 14, 2018 (http://nnw.fm/zf2UE).
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences (OTCQB: PBIO) recently entered a global co-marketing and distribution agreement with ISS, Inc. to create an advanced high pressure optical spectroscopy system utilizing PBIO’s patented pressure cycling technology (“PCT”). An article further discussing the agreement reads: “A leading developer and provider of innovative high pressure-based solutions to the global life sciences industry, Pressure BioSciences, Inc. (OTCQB: PBIO) has entered a two-year agreement with ISS, Inc., a prominent designer and manufacturer of advanced scientific instruments with more than 30 years of experience in the field. Under the agreement, the two companies will join their marketing and distribution efforts worldwide, as well as their own technologies to create an advanced high pressure optical spectroscopy system that’s expected to generate significant data that could be critical to the discovery and development of new biopharmaceutical diagnostics and drugs, according to a Pressure BioSciences press release issued on February 14, 2018 (http://nnw.fm/zf2UE).
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)